Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

n.v. organon - корифолитропин алфа - reproductive techniques, assisted; ovulation induction; investigative techniques - Полови хормони и слиза на половата система, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

nv organon - Хорионгонадотропин - 1500 iu powder and solvent for solution for injection

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

nv organon - Хорионгонадотропин - 5000 iu powder and solvent for solution for injection

Bulgarija - bulgarų - БАБХ (Българска агенция по безопасност на храните)

Сева Анимал Хелт България ЕООД - Един конете суроватъчен гонадотропин - лиофилизат и разтворител за инжекционен разтвор - 500 iu - говеда, овце

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

gedeon richter plc. - фолитропин алфа - Ановулация - Полови хормони и слиза на половата система, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. В клинични проучвания при тези пациенти са били идентифицирани ендогенен нивото на серумните нива на lh < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Europos Sąjunga - bulgarų - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - дегареликс - Простатни неоплазми - Ендокринна терапия - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

ferring gmbh - Човешки гонадотропин менопаузальный - 75 iu/75 iu powder and solvent for solution for injection

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

ferring gmbh,wittland 11,d-24109kiel - Човешки гонадотропин менопаузальный - 75 iu powder and solvent for solution for injection

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

ibsa farmaceutici italia srl - Човешки гонадотропин менопаузальный - 75 iu powder and solvent for solution for injection

Bulgarija - bulgarų - Изпълнителна агенция по лекарствата

ibsa farmaceutici italia srl - Човешки гонадотропин менопаузальный - 150 iu powder and solvent for solution for injection